2024 Annual Meeting | H107 - The Ultimate Fixer—Fixing Prior Authorization in Your Own Backyard (Practice and Policy Hub)

Date Monday 04/15/24

Time 01:30 PM - 02:00 PM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Practice and Policy)

Director(s) Kavita Nair, PhD, FAAN, Gabriela De Bruin, MD, Anelyssa D'Abreu, MD, PhD, MPH, FAAN

Topic(s) Practice, Policy, and Ethics

Learning Objectives A central approach to achieving high-quality neurologic care is to reduce the burden on providers in accessing services needed to achieve this level of care. Neurology-based practices across the continuum (solo, multispecialty, hospital, or health system–based) have adopted different methods to mitigate the impact of gatekeeper methods of prior authorization and related mechanisms. Participants should become familiar with ways to partner with payers through innovative Gold Carding programs that reduce the burden of gatekeeper mechanisms on neurology providers, thereby allowing them to consistently focus their efforts in the provision of high-quality neurologic care.

CME Available 0.50 CME credit

Core Competencies Patient Care & Procedural Skills, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Business Administrator

Teaching Styles Case-based, Audience Participation

Program Evaluations

Event Timeline
01:30 PM - 02:00 PM MDT	Speaker	The Ultimate Fixer—Fixing Prior Authorization in Your Own Backyard Kavita Nair, PhD, FAAN, Gabriela De Bruin, MD, Anelyssa D'Abreu, MD, PhD, MPH, FAAN

Faculty Disclosures
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Gabriela De Bruin, MD	An immediate family member of Dr. De Bruin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. De Bruin has stock in Neuroquestions LLC. An immediate family member of Dr. De Bruin has stock in Neuroquestions LLC.
Anelyssa D'Abreu, MD, PhD, MPH, FAAN	The institution of Dr. D'Abreu has received research support from U.S. NIH Institute on Aging. The institution of Dr. D'Abreu has received research support from Biogen. The institution of Dr. D'Abreu has received research support from American College Of Radiology. The institution of Dr. D'Abreu has received research support from COGNITION THERAPEUTICS, INC.. The institution of Dr. D'Abreu has received research support from Eli Lilly. The institution of Dr. D'Abreu has received research support from Jansen. Dr. D'Abreu has received personal compensation in the range of $10,000-$49,999 for serving as a Lecturer with Pri_med.

��ɫ��

��ɫ��